Crucible Value Proposition
Speed to market, regulatory compliance and fitness for purpose. A faster return on investment.
What we do.
Crucible Medtech is a medical device developer and consultancy specialising in ophthalmology.
We work with doctors, patients, buyers and payers to understand clinical need, user requirements and market fit.
We work with inventors in universities and health boards to identify cutting edge innovation that can be taken forward into high-impact products.
We marry the need with the innovation and use our deep knowledge of medical device commercialisation to develop products that are clinically and commercially fit for purpose, compliant with regulatory requirements and reimbursable in their target healthcare markets.
Why we do it
Crucible was founded in 2015 by Peter Estibeiro, John Wigham and Steve Howell in response to a Scottish Enterprise review of med tech strategy for Scotland.
Peter, John and Steve are serial entrepreneurs with a deep understanding of med tech and life sciences commercialisation strategies and the role that effective, regulated design, development and manufacturing plays in accelerating a product onto the market, ensuring it is fit for purpose, and maximising life-time value for all stakeholders.
Our value proposition has, at its core, speed to market and fitness for purpose.
Meet the Team
Crucible Medtech board and management team
Peter has over 15 years experience in the life sciences and medical technology sectors. He has been involved in the foundation or leadership of seven early stage companies including Crucible. Previously as CEO of i2eye diagnostics he led the commercialisation of i2eye's ophthalmology device from concept to market in 10 months and i2eye was awarded best new life science company in Scotland 2013.
Co-founder, Manufacturing Director
John has over 25 years manufacturing experience with large multinational companies, new start-ups and SMEs. He was previously Managing Director of a contract manufacturer with three facilities and led through a substantial restructuring to achieve increased profitability through efficiency, growth and cultural change. John also has substantial experience of SME product realisation through his work as Director of the Product Realisation Centre at Napier University.
Co- founder, Commercialisation Director
Steve is CEO of Innova Partnerships, a company that builds and grows life Science enterprises through partnering and investment. Recent examples of companies built include Reminova Ltd, Relaymed Ltd and Biotangents Ltd. Steve and the Innova Partnerships team bring a wealth of experience in Life Science commercialisation and an understanding of the challenges facing companies scaling for manufacture. Steve is currently visiting professor of Commercial Innovation at Kings College London.
Saltire Fellow (2016)
The Saltire Fellowship is a world renowned business leadership programme rooted in Scotland. Crucible was privileged to host Troy for three months after his time spent at Babson College in Boston USA. Troy worked as business development manager and was instrumental in challenging and validating Crucible's early business model and in laying the foundations for the ongoing and future development of the company.
Our products and Services
Accelerating high impact products to market
Proprietary pipeline, ophthalmic innovation
Firstly, we are developing a portfolio of ophthalmic products themed around the early diagnosis, management and ultimate cure of degenerative eye disease. We identify and develop technologies through collaboration with leading universities and clinical research centres. We raise the necessary funding and manage the development, validation and marketing of resulting products. It is our goal to create a pipeline of three to five high-impact, Crucible-branded ophthalmic products reaching the market within the next five years.
If you work in university tech transfer and have a licensing or co-development opportunity that we might be interested in then we want to hear from you. Please contact us for a no obligation informal discussion.
Specialist consultancy, product realisation
Secondly, we support entrepreneurs and innovators by offering our extensive medical and life sciences commercialisation capability and international networks on a fee-for-service consultancy basis. This is tapping into the core of our value proposition, we understand customer discovery, regulation, reimbursement and both clinical and commercial validation. We can take a lot of pain out of the process, help build a strong business case for investment and make sure that your products are fit for purpose at each stage of scale.
Download our consultancy flyer here.
Please contact us for a quote or an informal preliminary discussion.
Inisghts and commentary from the Crucible Medtech team
Case Studies / Clients
Some examples of what we do
We are evaluating three very exciting technologies and we will post updates here whenever we can during 2017.
Tools and Educational resources
We use a range of proprietary tools and resources to assess the stage of readiness of a technology and to plan a commercialisation strategy ensuring key milestones are achieved including: essential regulatory requirements, device classification, validation of market requirement specification and appropriate design for manufacture.
We hope to make these available as an online resource for clients and collaborators during 2017, meanwhile please contact us for assistance.
Please sign up and we'll keep you informed of developments, new resources and Crucible events.